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Abstract
In Candida albicans, lipid rafts (also called detergent-resistant membranes, DRMs) are involved in many cellular processes
and contain many important proteins. In our previous study, we demonstrated that Rta2p was required for calcineurin-
mediated azole resistance and sphingoid long-chain base release in C. albicans. Here, we found that Rta2p was co-localized
with raft-constituted ergosterol on the plasma membrane of C. albicans. Furthermore, this membrane expression pattern
was totally disturbed by inhibitors of either ergosterol or sphingolipid synthesis. Biochemical fractionation of DRMs together
with immunoblot uncovered that Rta2p, along with well-known DRM-associated proteins (Pma1p and Gas1p homologue),
was associated with DRMs and their associations were blocked by inhibitors of either ergosterol or sphingolipid synthesis.
Finally, we used the proteomic analysis together with immunoblot and identified that Rta2p was required for the
association of 10 proteins with DRMs. These 5 proteins (Pma1p, Gas1p homologue, Erg11p, Pmt2p and Ali1p) have been
reported to be DRM-associated and also that Erg11p is a well-known target of azoles in C. albicans. In conclusion, our results
showed that Rta2p was predominantly localized in lipid rafts and was required for the association of certain membrane
proteins with lipid rafts in C. albicans.
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Introduction
Candida albicans is a dimorphic opportunistic pathogen which
causes a wide variety of infections ranging from relatively focused
infection like superficial mycoses in generally healthy individuals to
life-threatening systemic infection candidiasis in individuals with
weakened immune systems [1,2]. C. albicans is now recognized as
one of the most common causes of bloodstream infection with high
mortality rate [3,4]. The limited availability of therapeutic arsenals
makes the study of its physiology critical in order to discover new
antifungal targets [5].
The plasma membrane distribution of C. albicans is asymmetric
with respect to sphingolipids, phospholipids and ergosterol [6].
Most, if not all, of the sphingolipids are present in the outer leaflet
while phospholipids are restricted to the inner leaflet [7]. The
process of phospholipids and sphingolipids moving within the lipid
bilayer is termed ‘‘flip-flop’’, which is driven by proteins termed
flippases/floppases [8]. ATP-binding cassette transporters (Cdr1p
and Cdr2p) are involved in the translocation of phospholipids from
the outer leaflet to the inner leaflet of the plasma membrane in C.
albicans [9,10]. That is because the asymmetrical distribution of
phospholipids between two monolayers of plasma membrane was
altered by over expression of CDR1 and CDR2 both in clinical and
in laboratory induced azole-resistant strains of C. albicans [11,12].
On the other hand, our previous study demonstrated that Rta2p
might be the floppase that moved long chain bases, the backbone
of sphingolipids, to outer leaflet of the plasma membrane in C.
albicans [13]. The distribution of ergosterol appears to have a high
rate of spontaneous flipping between two leaflets [14]. Due to the
observed preferential interaction between ergosterol and sphingo-
lipids, it is likely that ergosterol is abundantly present in the outer
leaflet [14].
The plasma membrane of C. albicans is also not homogeneous in
their lipid composition. There are some membrane regions that
contain higher concentration of ergosterol and sphingolipids
[14,15]. These regions are more organized than the rest of the
membrane due to a higher amount of saturated acid chains and
are therefore called lipid rafts [14,15]. The compositions in lipid
rafts are tightly packed structures which make raft insoluble in
non-ionic detergents like Triton X-100 at low temperature [16].
For this reason, lipid rafts are also named detergent-resistant
membranes (DRMs). In addition to C. albicans [17,18], lipid rafts
have been also identified in Saccharomyces cerevisiae [19,20,21] and in
Schizosaccharomyces pombe [22]. In all of these organisms, lipid rafts
have been found to be involved in important biological processes
like mating [23], cytokinesis [22] and hyphal formation [17]. Their
protein compositions are heterogeneous including both trans-
membrane (TM) proteins and glycosylphosphatidylinositol (GPI)-
anchored proteins [14]. The multi-drug resistance transporter
Cdr1p, a phospholipid translocase, is predominantly localized in
lipid rafts in C. albicans [24,25]. Depletion of ergosterol or
sphingolipids from raft regions impairs Cdr1p-mediated drug
transport in a substrate- and cell-type-specific manner [24,25,26].
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translocase, and lipid rafts remain elusive.
In the present study, we found that Rta2p is not only present in
the plasma membrane but also localized in lipid rafts of C. albicans.
Furthermore, Rta2p was found to be required for the association
of certain membrane proteins with lipid rafts in C. albicans.
Results
Rta2p was unevenly present in the plasma membrane of
C. albicans
Rta2p has been reported to be an integral membrane protein
predicted with seven TM segments in C. albicans [27]. In order to
explore the subcellular localization of Rta2p, we constructed the C.
albicans strain (Table 1) wherein one RTA2 allele was fused with the
GFP-URA3 cassette, while maintaining the native promoter
sequence. The correct fusion of RTA2 and GFP in the RM-GFP
strain was verified by PCR using a primer pair specific for RTA2
and GFP (Figure S1). It has been shown that the disruption of
either one or two RTA2 alleles in C. albicans displayed an increased
sensitivity specifically to azoles [13]. In the present study, we found
that the RM-GFP strain rendered similar sensitivities to azoles
including fluconazole and voriconazole with the wild-type strain
(Figure 1), which indicated that the Rta2p-GFP was functionally
expressed in the transformed strain. The Rta2p-GFP fluorescence
was observed to be unevenly present in the cell surface of
transformed live C. albicans cells (Figure 2A). Furthermore, the
transformed cells were co-stained with filipin, which has been used
to visualize membrane sterols [28]. As evident in Figure 2B, the
fluorescence of Rta2p-GFP and filipin staining were co-localized
in the plasma membrane of C. albicans, indicating that Rta2p was
an integral membrane protein.
It has been well documented that ergosterol is a major
constituent of lipid rafts and its biosynthesis inhibitors including
fluconazole can effectively destroy the formation of lipid rafts [26].
Confocal images of fluconazole-treated C. albicans cells showed that
Rta2p-GFP was mainly present in the intracellular compartments
(Figure 2C). A similar observation was also made when myriocin
was administered to inhibit the first step biosynthesis of
sphingolipid [29], another major constituent of lipid rafts [30] in
C. albicans (Figure 2C). Therefore, these data imply that Rta2p
might be associated with lipid rafts in C. albicans.
Rta2p was predominantly localized in lipid rafts and its
association was blocked by either fluconazole or
myriocin
DRMs were isolated by a detergent insolubility method with the
nonionic detergent Triton X-100 [31]. Optiprep gradient centri-
fugation was performed wherein DRM portions generally
constituted the upper three fractions when eight equal fractions
from top to bottom were taken (Figure 3A). The raft preparation
was verified by the immunoblot with polyclonal antibodies against
Pma1p and Gas1p homologue (Figure 3B), which are known to be
DRM-associated in C. albicans [18]. Pma1p was preferentially
detected in the upper three fractions and Gas1p homologue was
primarily located in fraction 1 from wild-type cells (Figure 3B).
Immunoblot analysis with polyclonal antibody against Rta2p
Figure 1. Drug susceptibility profiles of C. albicans strains (Table 1) as determined by spot assays. C. albicans strains including wild-type
(RM1000), RM-GFP and rta2D/D::RTA2 strains were spotted on YPD agar plates with or without different antifungal agents at indicated concentrations.
Plates were incubated for 24 h at 35uC.
doi:10.1371/journal.pone.0037768.g001
Figure 2. Analysis of fluorescent protein fusions in C. albicans.
(A) Immunofluorescence mapping of Rta2p-GFP. Overlay (left), fluores-
cence (centre) and bright field (right) images are shown individually. (B)
Co-localization of ergosterol-rich domains stained by filipin and Rta2p-
GFP of C. albicans. The cells were stained with 10 mg of filipin/ml for
10 min and then analyzed by fluorescence microscopy. Merged image
(left), Filipin staining (centre) and Rta2p-GFP (right). (C) Immunofluo-
rescence mapping of Rta2-GFP in C. albicans after exposure to FLC
(8 mg/ml) or myriocin (0.4 mg/ml) for 16 h. Bar, 5 mm.
doi:10.1371/journal.pone.0037768.g002
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* RTA2/rta2D::RTA2-GFP-URA3 This study
rta2D/D JXM100 RM1000
*rta2D::hisG/rta2D::hisG [13]
rta2D/D::RTA2 rta2D/D RM1000*rta2D::hisG/rta2D::hisG ADE2/ade2::RTA2/URA3 This study
*RM1000 background.
doi:10.1371/journal.pone.0037768.t001
Figure 3. Relationships of Rta2p and DRMs in C. albicans. (A) Membranes were extracted with Triton X-100 and floated in an Optiprep
gradient, as described in Materials and Methods. Fractions of equal volumes were removed from the top of the gradient and analyzed by Western
blots. (B) Membranes proteins extracted from WT cells were analyzed on Western blots probed with antibodies against Pma1p, Gas1p homologue
and Rta2p. (C) Membranes proteins extracted from WT cells after exposure to fluconazole (8 mg/ml) for 16 h were analyzed on Western blots probed
with antibodies against Pma1p, Gas1p homologue and Rta2p. (D) Membranes proteins extracted from WT cells after exposure to myriocin (0.4 mg/ml)
for 16 h were analyzed on Western blots probed with antibodies against Pma1p, Gas1p homologue and Rta2p. (E) Membranes proteins extracted
from rta2D/D cells were analyzed on Western blots probed with antibodies against Pma1p and Gas1p homologue. (F) Membranes proteins extracted
from rta2D/D::RTA2 complemented cells were analyzed on Western blots probed with antibodies against Pma1p and Gas1p homologue.
Representative data are shown from three independent experiments.
doi:10.1371/journal.pone.0037768.g003
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fraction 1 (Figure 3B), indicating its association with DRMs.
It has been well documented that raft association of Pma1p and
Gas1p homologue to the plasma membrane are dependent upon
ergosterol or sphingolipid synthesis in yeast [32,33]. We then
examined the effect on the association of Rta2p with DRMs in C.
albicans following the treatment of inhibitors (Figure 3 C and D).
After exposure to fluconazole for 16 hours, the quantity of Pma1p
and Gas1p homologue associated with DRMs was notably
reduced and the association of Rta2p with DRMs was also
blocked (Figure 3C). Following the treatment of myriocin, similar
results were obtained for Pma1p, Gas1p homologue and Rta2p
(Figure 3D). These results biochemically verified that Rta2p,
together with well-known DRM-associated proteins (Pma1p and
Gas1p homologue), was predominantly localized in DRMs and
their association were blocked by either fluconazole or myriocin.
The disruption of RTA2 blocked the association of Pma1p
and Gas1p homologue with DRMs
The localization of Rta2p in lipid rafts prompted us to
investigate whether its important roles in developing fluconazole
resistance were actually mediated by its regulatory effects in the
formation of lipid rafts. First, we examined the effects of Rta2p on
the synthesis of ergosterol in C. albicans. Consistent with our
previous report [13], the disruption of RTA2 had no influence on
the synthesis of ergosterol (Table S1). The quantity of ergosterol
from DRMs was measured by GC-MS and no significant
differences were found between the wild-type, rta2D/D mutant
and rta2D/D::RTA2 complemented strains (Table 2). Spot assay
showed that the rta2D/D::RTA2 complemented strain rendered
similar sensitivities to azoles including fluconazole and voricona-
zole with wild-type strain (Figure 1), which confirmed that the
function of Rta2p had been restored.
Next, we investigated the effects of Rta2p on the association of
membrane proteins with DRMs. Unlike wild-type cells (Figure 3B),
the quantity of Pma1p and Gas1p homologue associated with
DRMs was greatly reduced in rta2D/D mutant cells (Figure 3E).
We further explored the influence of restoring the function of
Rta2p on DRM-associations of Pma1p and Gas1p homologue. As
shown in Figure 3F, re-introduction of one RTA2 allele into rta2D/
D mutant cells restored the recruitment of Pma1p and Gas1p
homologue to DRMs. Therefore, the disruption of RTA2 did not
interfere with the formation of lipid rafts. However, it appeared to
block the association of well-known raft-associated proteins
including Pma1p and Gas1p homologue with lipid rafts.
Proteomic analysis of the DRM-associated proteins
affected by the disruption of RTA2
The influences on the association of membrane proteins with
lipid rafts by Rta2p convinced us to use the proteomic analysis to
identify other DRM-associated proteins, which were affected by
the disruption of RTA2. We identified 9 differential proteins, the
amount of which was significantly reduced in DRMs of rta2D/D
mutant cells compared with wild-type cells (Figure 4). These 9
identified proteins were involved in protein modification (Pmt1p
and Pmt2p), electron transport (Pma1p and Ali1p), lipid metab-
olism (Erg11p and Vtc2p), transporter (Mlt1p), protein binding
(Ssb1p) as well as unknown functional protein (Lsp1p) (Table 3).
These results implied that the disruption of RTA2 might have
blocked the association of membrane proteins with DRMs and
promoted the impairment of fluconazole to the plasma membrane
of C. albicans.
Discussion
Rta2p has been reported to be an integral membrane protein
predicted with seven TM segments in C. albicans [27]. Our
previous study demonstrated that Rta2p, like its S. cerevisiae
homolog Rsb1p [34], is a translocase that moves sphingolipid long
chain bases from the inside to the outside of the membrane in C.
albicans [13]. In this study, we observed that the plasma membrane
distribution between Rta2p and Rsb1p was different. Rta2p,
Table 2. Percentage of ergosterol in every two fractions of
the gradients from rafts to non-rafts.







Wild-type 62.5 8.3 13.2 16.0
rta2D/D 71.7 11.0 10.2 7.1
rta2D/D::RTA2 74.7 8.2 8.4 11.6
aErgosterol proportions varied by less than 10% in three experiments.
bFraction 1–2 (F1–2), 3–4 (F3–4), 5–6 (F5–6) and 7–8 (F7–8) of eight equal fractions
from top to bottom after Optiprep gradient centrifugation.
doi:10.1371/journal.pone.0037768.t002
Figure 4. Proteomic analysis of the DRM-associated proteins
affected by the disruption of RTA2. DRM membrane fractions,
extracted from wild-type (WT) and rta2D/D mutant cells as described in
Materials and Methods, were separated by 8% and 12% polyacrylamide
gels. Representative data are shown from three independent experi-
ments.
doi:10.1371/journal.pone.0037768.g004
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the plasma membrane on C. albicans. Whereas Rsb1p had been
found to be continuously and evenly distributed on membranes of
cells, endoplasmic reticulum and the endosomes in S. cerevisiae [34].
Furthermore, the normal uneven distribution of Rta2p requires
the normal synthesis of ergosterol or sphingolipid, which are
known to be rich in lipid rafts [14,15]. This disrupted distribution
of membrane proteins was also observed on proteins known to be
raft-associated when ergosterol or sphingolipid synthesis was
inhibited [32]. The plasma membrane H
+-ATPase Pma1p is
known to be associated with DRMs [32]. Pma1p-GFP displayed
a characteristic ring-like staining at the cell periphery while drug-
induced inhibition of sphingolipid synthesis resulted in vacuolar
localization of Pma1p-GFP in S. cerevisiae [30]. The raft-associated
and multi-drug resistant protein Cdr1p was properly localized on
the surface of wild-type Candida cells while the fluorescence of
Cdr1p-GFP appeared to be concentrated inside the mutant cells
with the sphingolipid biosynthetic gene IPT1 disrupted [26].
Therefore, Rta2p might be like Pma1p and Cdr1p and raft-
associated in C. albicans.
A recent proteomic study of DRMs from C. albicans identified 29
proteins probably localized within membrane rafts including well-
known proteins associated with lipid rafts in S. cerevisiae [16] like
Pma1p and the GPI-anchored protein Ecm33p (S. cerevisiae Gas1p
homologue) [18]. However, Rta2p was not in the list and some
known raft-associated proteins including amino acid permease
Fur4p, Tat2p, and transporters Cdr1p, Can1p and Nce2p were
also not identified in the proteomic analysis of DRMs from C.
albicans [18,35,36]. In our study, Rta2p, along with Pma1p and
Gas1p homologue, was found to be predominantly localized in
lipid rafts (Figure 3B) and the raft-association of Rta2p was
blocked by inhibitors of either ergosterol or sphingolipid synthesis
in C. albicans, as determined by raft isolation (Figure 3C).
Furthermore, the disruption of RTA2 blocked the raft-association
of membrane proteins (Pma1p and Gas1p homologue) and re-
introduction of one RTA2 allele into rta2 mutant lead to the
recruitment of these proteins to lipid rafts (Figure 3). Proteomic
analysis revealed that, besides Pma1p, the disruption of RTA2
inhibited the raft-association of other 8 proteins (Figure 4), ordered
in Table 3 according to their function. Of these proteins, 4
(Pmt2p, Pma1p, Erg11p and Ali1p) had been found in lipid rafts
[18].
The requirement of Rta2p for raft-association with Erg11p is
very interesting because it is a well-known target of azoles, which
results in predominance of toxic 14a-methylated sterols and
inhibition of subsequent reactions of the ergosterol biosynthesis
pathway in C. albicans [37]. Ergosterol is not only the major sterol
in fungal cell membranes but also the major lipid raft-component.
However, Rta2p affects neither the synthesis of ergosterol nor the
distribution of ergosterol in lipid rafts (Table S1 and Table 2).
Therefore, the disruption of RTA2 does not affect the function of
Erg11p, but blocks the association of Erg11p with lipid rafts.
We also identified that the raft-association of mannosyltrans-
ferases including Pmt1p and Pmt2p were required for Rta2p.
Proteins from the Pmt family initiate O-mannosylation of
secretory proteins. Functional analysis of the Pmt gene family in
C. albicans indicates that Pmt isoforms have variable and specific
roles for in vitro and in vivo growth, morphogenesis and antifungal
resistance [38,39]. The raft-association of a member of the HSP70
family, Ssb1p, is also identified to be required for Rta2p. Of note,
a member of the HSP70 family (Ssa1p) and a heat shock cognate
protein have been found in lipid rafts [18,40], and the antibody
against Ssa1p has been found in patients with systemic candidiasis
[41].
In conclusion, Rta2p is predominantly localized in lipid rafts
and the raft-association of Rta2p is blocked by inhibiting either
ergosterol or sphingolipid synthesis. More importantly, the raft-
association of certain membrane proteins is blocked by the
disruption of RTA2. However, the mechanisms involved remain
undetermined.









Pmt1p Protein mannosyltransferase 100 30 28 11 CA4424
Pmt2p Protein mannosyltransferase 88 20 21 8 CA5894
Electron transport
Pma1p Plasma membrane H(+)-ATPase 100 25 29 8 CA2300
Ali1p Putative NADH-ubiquinone oxidoreductase 32.5 18 40 CA1557
Transporter
Mlt1p Vacuolar membrane transporter 180 35 18 17 CA2221
Lipid metabolism
Erg11p Lanosterol 14-alpha-demethylase 60.7 26 47 2 CA1387
Vtc2p Putative polyphosphate synthetase 91.5 28 33 2 CA3918
Protein binding
Ssb1p HSP70 family heat shock protein 66.4 16 33 CA3534
Unknown function
Lsp1p sphingolipid long chain base-responsive protein 35.6 10 29 CA0622
a)Protein name and accession number according to Candida DB: http://genolist.pasteur.fr/CandidaDB.
b)Experimental Mr( 610
23).
c)Number of peptide masses matching the top hit from MASCOT PMF.
d)Amino acid sequence coverage for the identified proteins.
e)TMHMM: Prediction of TM helices in proteins: http://www.cbs.dtu.dk/services/TMHMM-2.0/.
doi:10.1371/journal.pone.0037768.t003
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GPI-anchored proteins were delivered from the endoplasmic
reticulum (ER) to the plasma membrane via lipid microdomains,
and DRM-associations with either TM, such as Pma1p, Tat2p,
Fur4p, and Can1p, or GPI-anchored proteins, such as Gas1p,
were initiated in the ER [21,33,35,42,43,44]. In a large scale
screen, 28 genes, involved in lipid biosynthesis and vesicle
transport, were identified to be required for raft-association of
membrane compartment of Can1 [45], which contains the
arginine transporter Can1p, two other proton symporters, Fur4p
and Tat2p, and three tetraspan proteins with unknown functions,
Sur7p, Fmp45p, and Ynl194c in S. cerevisiae [36,46,47]. Of note,
the cytosolic protein Lsp1p of S. cerevisiae was colocalized with the
membrane compartment of Can1 marker Sur7p [48], whereas the
raft-association of C. albicans homolog Lsp1p was blocked by the
disruption of RTA2 in our study (Figure 4).
A recent study has demonstrated that sphingolipids are not
necessary for raft-association of Pma1p but that the C26 fatty acid,
which forms part of the yeast ceramide, is crucial [30]. Therefore,
it is most likely that ceramide is essential for the specific transport
of both TM and GPI-anchored proteins from the ER to the Golgi
[49,50,51,52]. The ceramide moiety consists of a sphingoid long-
chain base (dihydrosphingosine and phytosphingosine) in yeast
[53]. Because the ER is the site of ceramide synthesis, the
generated long-chain bases must be delivered to the ER. Our
previous study demonstrated that Rta2p was required for
translocating long chain bases from the cytoplasmic side toward
the extracytoplasmic side of the membrane [13]. Therefore, the
disruption of RTA2 may block the raft-association of certain
membrane proteins by affecting the synthesis of ceramide.
Materials and Methods
Materials
Fluconazole was from Pfizer Inc (New York, N.Y.). Myriocin
and filipin were purchased from Sigma (St. Louis, Mo.). Optiprep
were also obtained from Sigma (St. Louis, Mo.). The protease
inhibitors (4-[2-aminoethyl]benzenesulfonyl fluoride hydrochlo-
ride, E-64, pepstatin A, 1,10-phenanthroline) were purchased from
Calbiochem (San Diego, CA). IRDye 680 goat anti-rabbit IgG was
from LI-COR Biosciences (Lincoln, NE).
C. albicans strains and culture media
C. albicans strains used in this study are listed in Table 1 and
cultured in YPD (1% yeast extract, 2% peptone, 2% glucose)
medium [13].
Construction of C. albicans RTA2-GFP reporter strains and
fluorescence assay
GFP reporter construction targeted for integration into specific
RTA2 loci was achieved using the method described previously
[54]. In detail, RTA2-specific sequences were added to the
universal primer sequences as described in Table S2 and used
for PCR amplification with the plasmid pGFP-URA3 as the
template to generate an integration cassette. This cassette was
designed so that it could be ‘knocked into’ the correct RTA2 locus,
thereby generating RTA2 heterozygote where one RTA2 allele was
replaced with the GFP-URA3 cassette, while maintaining the
native promoter sequence. PCR products were amplified using
Pyrobest polymerase (TaKaRa) and were transformed into the
ura3D/D mutant (RM1000) by standard methods [13], yielding the
strains carrying chromosomal C-terminal RTA2-GFP fusions.
Confocal imaging of the strain expressing Rta2p-GFP was
performed under an oil immersion objective at 6100 magnifica-
tion under a confocal microscope (Leica TCS SP5). For
colocalization studies, C. albicans strain expressing RTA2-GFP
was stained with 10 mg/ml filipin for 10 min and then analyzed by
fluorescence microscopy [17].
Construction of RTA2 revertants
All the primer sequences are listed in Table S2. The fragment
containing ORF of RTA2 and its 1 kb up/downstream were
amplified by PCR with Pyrobest polymerase (TaKaRa). The PstI-
KpnI digested PCR fragments were ligated into plasmid pBes116
[55] to obtain plasmids pBes-RTA2. And then, the AscI digested
fragments of pBes-RTA2 were transformed into rta2D/D mutant
as before [13]. Re-introduction of one RTA2 allele into rta2D/D
mutant at the ade2 locus was verified by PCR (Figure S2). The up-
regulation of RTA2 in the rta2D/D::RTA2 complemented strain by
calcium signaling was verified by quantitative RT-PCR (Figure
S2).
Susceptibility testing
Drug sensitivity was assayed on YPD agar plates containing
drugs at the indicated concentrations as described previously [13].
DMSO, the drug vehicle, was #0.5% in all cases. Five microliters
of tenfold serial dilutions of each yeast culture (OD600=1.0) was
spotted on the appropriate medium plates and then incubated at
35uC for 24 h.
DRM isolation and Western blot analysis
The isolation of detergent-resistant membranes (DRMs) was
performed as described previously [56]. Briefly, a logarithmically
growing C. albicans culture in YPD (OD600=1) was collected by
centrifugation and lyophilized. Biomass dry weight was de-
termined. Cell pellet was resuspended in 500 ml cold TNE buffer
(50 mMTris-Cl, pH7.4, 150 mM NaCl, 5 mM EDTA) plus
protease inhibitors (final concentrations of 0.2 mM 4-[2-ami-
noethyl]benzenesulfonyl fluoride hydrochloride, 3 mM E-64,
4 mM pepstatin A, 1 mM 1,10-phenanthroline (Calbiochem),
and broken by vortexing with a 0.5 volume of glass beads for 6
cycles (30 s of vortexing followed by 30 s on ice). Unbroken cells
and beads were removed by centrifugation for 15 min at 5006g.
Total membranes were collected by centrifugation (30 min at
58,0006 g) and resuspended in 50 ml of TNE buffer. Total
quantity of protein was at this stage determined by the Bradford
method. A defined amount of total protein (2.5 mg) was trans-
ferred to a microtube and added 450 ml of TNE buffer. Triton X-
100 was added to a final concentration of 1%, and the mixture was
incubated for 30 min on ice. The chilled supernatant fluid (465 ml)
was adjusted to 40% Optiprep by adding 930 ml Optiprep solution
(Sigma) and overlaid with 2.2 ml 30% Optiprep in TXNE (TNE
plus 0.1% Triton X-100) and 370 ml TXNE. The samples were
centrifuged at 200 0006g for 4 h in a P55ST2 rotor (Hitachi).
Eight fractions of equal volume (460 ml) from top to bottom were
collected, and proteins were precipitated by adding two volumes of
15% trichloroacetic acid (final concentration 10%) for 30 min on
ice. Precipitated proteins were collected by centrifugation in
a microcentrifuge for 20 min at 4uC, and the pellet was dissolved
in 15 ml of 1 M Tris base and 35 ml of dissociation buffer (0.1 M
Tris-Cl, pH 6.8, 4 mM EDTA, 4% SDS, 20% glycerol, 2% 2-
mercaptoethanol, 0.02% bromphenol blue). Samples were heated
at 37uC for 15 min.
SDS-PAGE was carried out on 8% polyacrylamide gels. The
following antibodies were used for immunoblotting: rabbit anti-
Gas1p (a gift from H. Riezman, University of Basel, Switzerland)
at 1:5000, rabbit anti-Pma1p (a gift from Guenther Daum Institute
of Biochemistry Graz University of Technology) at 1:5000 and
Rta2p-Dependent DRMs in Candida albicans
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using Infrared IRDye-labeled anti-rabbit IgGs (LI-COR) and an
infrared imaging system (Odyssey).
MS analysis and database searches
DRMs were separated by 8% and 12% polyacrylamide gels and
stained with Coomassie blue G dye. The gel bands of visual
difference between the wild-type and rta2D/D mutant cells were
manually excised and subjected to in-gel trypsin digestion and
subsequent MALDI-TOF/TOF identification as described pre-
viously [57]. Combined MS and MS/MS spectra were submitted
to MASCOT (V2.1, Matrix Science, London, U.K.) by GPS
Explorer software (Applied Biosystems) and searched with the
following parameters: NCBI nr database, taxonomy of fungi,
trypsin digest with one missing cleavage, none fixed modifications,
MS tolerance of 0.1 Da, MS/MS tolerance of 0.8 Da, and
possible oxidation of methionine. Known contaminant ions
(keratin) were excluded. MASCOT protein scores (based on
combined MS and MS/MS spectra) of greater than 72 were
considered statistically significant (p#0.05). The individual MS/
MS spectrum with a statistically significant (confidence interval
.95%) best ion score (based on MS/MS spectra) was accepted.
To eliminate the redundancy of proteins that appeared in the
database under different names and accession numbers, the single-
protein member belonging to the species Gallus or else with the
highest protein score (top rank) was singled out from the multi-
protein family.
Sterol analysis
Samples preparation, sterols isolation, sterol identification, and
sterols analysis were done as described previously [13].
Supporting Information
Figure S1 Verification of the correct fusion of RTA2 and
GFP in C. albicans. The C. albicans strain (RM-GFP) carrying
chromosomal C-terminal RTA2-GFP fusions, yielded one 1.79 kb
PCR product by PCR analysis with the forward primer specific to
RTA2 and the reverse primer specific to GFP, with the wild-type
strain (RM1000) as control.
(JPG)
Figure S2 Verification of the re-introduction of one
RTA2 allele into rta2D/D mutant. (A) The rta2D/D::RTA2
complemented strain (JXM201), with one allele of RTA2
reintroduced into ADE2 locus, yielded only one 3.8 kb PCR
product by PCR analysis with the forward primer to ADE2 and the
reverse primer specific to RTA2, with the plasmid pBes-RTA2 as
control. (B) Expression levels of RTA2 were examined by
quantitative RT-PCR in the wild-type strain (RM1000) and the
rta2D/D::RTA2 complemented strain (JXM201) after exposure to
1 mM CaCl2 for 16 h, with their corresponding drug-free strains
as controls.
(JPG)
Table S1 The content of sterol compositions from C. albicans
wild-type and rta2D/D mutant strains.
(DOC)
Table S2 Primers used in this study.
(DOC)
Acknowledgments
We thank J. Pla for kindly providing the C. albicans strain RM1000, and
Cheryl A. Gale for providing plasmid pGFP-URA3. We also thank H.
Riezman and R. Serrano for the antibodies (anti-Gas1p and anti-Pma1p)
and Xiao-Ping Chen (Tongji University School of Medicine) for critically
reading my manuscript.
Author Contributions
Conceived and designed the experiments: LW X-MJ Y-YJ. Performed the
experiments: LW YJ. Analyzed the data: LW X-MJ. Contributed reagents/
materials/analysis tools: R-JT Y-BC ZX. Wrote the paper: LW X-MJ.
References
1. Meroni V, Zerrilli E, Genco F, Nocita B, Poletti F, et al. (2006) Infection in the
immunocompromised host (except HIV). Clin Microbiol Infect 12: 679–940.
2. Garber G (2001) An overview of fungal infections. Drugs 61: 1–12.
3. Richardson MD (2005) Changing patterns and trends in systemic fungal
infections. J Antimicrob Chemother 56: i5–i11.
4. Ruhnke M (2006) Epidemiology of Candida albicans infections and role of non-
Candida-albicans yeasts. Curr Drug Targets 7: 495–504.
5. Brown E, Wright G (2005) New targets and screening approaches in
antimicrobial drug discovery. Chem Rev 105: 759–774.
6. Van Meer G, Voelker DR, Feigenson GW (2008) Membrane lipids: where they
are and how they behave. Nat Rev Mol Cell Biol 9: 112–124.
7. Futerman AH, Riezman H (2005) The ins and outs of sphingolipid synthesis.
Trends Cell Biol 15: 312–318.
8. van Meer G, Halter D, Sprong H, Somerharju P, Egmond MR (2006) ABC lipid
transporters: extruders, flippases, or flopless activators? FEBS letters 580:
1171–1177.
9. Krishnamurthy S, Dixit B, Gupta C, Milewski S, Prasad R (2002) ABC
transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans
are general phospholipid translocators. Yeast 19: 303–318.
10. Shukla S, Rai V, Saini P, Banerjee D, Menon AK, et al. (2007) Candida drug
resistance protein 1, a major multidrug ATP binding cassette transporter of
Candida albicans, translocates fluorescent phospholipids in a reconstituted
system. Biochemistry 46: 12081–12090.
11. Kohli A, Smriti N, Mukhopadhyay K, Rattan A, Prasad R (2002) In vitro low-
level resistance to azoles in Candida albicans is associated with changes in
membrane lipid fluidity and asymmetry. Antimicrob Agents Chemother 46:
1046–1052.
12. Mishra N, Prasad T, Sharma N, Prasad R, Gupta D (2007) Membrane fluidity
and lipid composition in clinical isolates of Candida albicans isolated from
AIDS/HIV patients. Acta Microbiol Immunol Hung 54: 367–377.
13. Jia X, Wang Y, Jia Y, Gao P, Xu Y, et al. (2009) RTA2 is involved in
calcineurin-mediated azole resistance and sphingoid long-chain base release in
Candida albicans. Cell Mol Life Sci 66: 122–134.
14. Wachtler V, Balasubramanian MK (2006) Yeast lipid rafts? An emerging view.
Trends Cell Biol 16: 1–4.
15. Pike LJ (2003) Lipid rafts. J Lipid Res 44: 655–667.
16. Kubler E, Dohlman HG, Lisanti MP (1996) Identification of Triton X-100
insoluble membrane domains in the yeast Saccharomyces cerevisiae. Lipid
requirements for targeting of heterotrimeric G-protein subunits. J Biol Chem
271: 32975–32980.
17. Martin SW, Konopka JB (2004) Lipid raft polarization contributes to hyphal
growth in Candida albicans. Eukaryot Cell 3: 675–684.
18. Insenser M, Nombela C, Molero G, Gil C (2006) Proteomic analysis of
detergent-resistant membranes from Candida albicans. Proteomics 6: S74–81.
19. Bagnat M, Simons K (2002) Lipid rafts in protein sorting and cell polarity in
budding yeast Saccharomyces cerevisiae. Biol Chem 383: 1475–1480.
20. Grossmann G, Opekarova M, Novakova L, Stolz J, Tanner W (2006) Lipid raft-
based membrane compartmentation of a plant transport protein expressed in
Saccharomyces cerevisiae. Eukaryot Cell 5: 945–953.
21. Malı ´nska ´ K, Malı ´nsky ´ J, Opekarova ´ M, Tanner W (2003) Visualization of
protein compartmentation within the plasma membrane of living yeast cells.
Mol Biol Cell 14: 4427–4436.
22. Wachtler V, Rajagopalan S, Balasubramanian MK (2003) Sterol-rich plasma
membrane domains in the fission yeast Schizosaccharomyces pombe. J Cell Sci
116: 867–874.
23. Bagnat M, Simons K (2002) Cell surface polarization during yeast mating. Proc
Natl Acad Sci U S A 99: 14183–14188.
24. Pasrija R, Panwar SL, Prasad R (2008) Multidrug transporters CaCdr1p and
CaMdr1p of Candida albicans display different lipid specificities: both ergosterol
and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.
Antimicrob Agents Chemother 52: 694–704.
25. Pasrija R, Prasad T, Prasad R (2005) Membrane raft lipid constituents affect
drug susceptibilities of Candida albicans. Biochem Soc Trans 33: 1219–1223.
26. Prasad T, Saini P, Gaur NA, Vishwakarma RA, Khan LA, et al. (2005)
Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in
Rta2p-Dependent DRMs in Candida albicans
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37768multidrug resistance and morphogenesis of Candida albicans. Antimicrob
Agents Chemother 49: 3442–3452.
27. Cabezo ´n V, Llama-Palacios A, Nombela C, Monteoliva L, Gil C (2009) Analysis
of Candida albicans plasma membrane proteome. Proteomics 9: 4770–4786.
28. Ghannoum MA, Rice LB (1999) Antifungal agents: mode of action, mechanisms
of resistance, and correlation of these mechanisms with bacterial resistance. Clin
Microbiol Rev 12: 501–517.
29. Dickson RC (1998) Sphingolipid functions in Saccharomyces cerevisiae:
comparison to mammals. Annu Rev Biochem 67: 27–48.
30. Gaigg B, Toulmay A, Schneiter R (2006) Very long-chain fatty acid-containing
lipids rather than sphingolipids per se are required for raft association and stable
surface transport of newly synthesized plasma membrane ATPase in yeast. J Biol
Chem 281: 34135–34145.
31. Mongrand S, Morel J, Laroche J, Claverol S, Carde J, et al. (2004) Lipid rafts in
higher plant cells: purification and characterization of Triton X-100-insoluble
microdomains from tobacco plasma membrane. J Biol Chem 279:
36277–36286.
32. Bagnat M, Chang A, Simons K (2001) Plasma membrane proton ATPase
Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell 12:
4129–4138.
33. Bagnat M, Kera ¨nen S, Shevchenko A, Simons K (2000) Lipid rafts function in
biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad
Sci U S A 97: 3254–3259.
34. Kihara A, Igarashi Y (2002) Identification and Characterization of aSacchar-
omyces cerevisiae Gene, RSB1, Involved in Sphingoid Long-chain Base Release.
J Biol Chem 277: 30048–30054.
35. Hearn J, Lester R, Dickson R (2003) The uracil transporter Fur4p associates
with lipid rafts. J Biol Chem 278: 3679.
36. Malinska K, Malinsky J, Opekarova M, Tanner W (2004) Distribution of Can1p
into stable domains reflects lateral protein segregation within the plasma
membrane of living S. cerevisiae cells. J Cell Sci 117: 6031–6041.
37. Sanglard D, Odds F (2002) Resistance of Candida species to antifungal agents:
molecular mechanisms and clinical consequences. Lancet Infect Dis 2: 73–85.
38. Prill SKH, Klinkert B, Timpel C, Gale CA, Schro ¨ppel K, et al. (2005) PMT
family of Candida albicans: five protein mannosyltransferase isoforms affect
growth, morphogenesis and antifungal resistance. Mol Microbiol 55: 546–560.
39. Timpel C, Strahl-Bolsinger S, Ziegelbauer K, Ernst JF (1998) Multiple Functions
of Pmt1p-mediated ProteinO-Mannosylation in the Fungal Pathogen Candida
albicans. J Biol Chem 273: 20837–20846.
40. Bini L, Pacini S, Liberatori S, Valensin S, Pellegrini M, et al. (2003) Extensive
temporally regulated reorganization of the lipid raft proteome following T-cell
antigen receptor triggering. Biochem J 369: 301–309.
41. Pitarch A, Abian J, Carrascal M, Sa ´nchez M, Nombela C, et al. (2004)
Proteomics-based identification of novel Candida albicans antigens for diagnosis
of systemic candidiasis in patients with underlying hematological malignancies.
Proteomics 4: 3084–3106.
42. Umebayashi K, Nakano A (2003) Ergosterol is required for targeting of
tryptophan permease to the yeast plasma membrane. J Cell Biol 161:
1117–1131.
43. Dupre ´ S, Haguenauer-Tsapis R (2003) Raft partitioning of the yeast uracil
permease during trafficking along the endocytic pathway. Traffic 4: 83–96.
44. Gaigg B, Timischl B, Corbino L, Schneiter R (2005) Synthesis of sphingolipids
with very long chain fatty acids but not ergosterol is required for routing of newly
synthesized plasma membrane ATPase to the cell surface of yeast. J Biol Chem
280: 22515–22522.
45. Grossmann G, Malinsky J, Stahlschmidt W, Loibl M, Weig-Meckl I, et al. (2008)
Plasma membrane microdomains regulate turnover of transport proteins in
yeast. J Cell Biol 183: 1075–1088.
46. Young ME, Karpova TS, Bru ¨gger B, Moschenross DM, Wang GK, et al. (2002)
The Sur7p family defines novel cortical domains in Saccharomyces cerevisiae,
affects sphingolipid metabolism, and is involved in sporulation. Mol Cell Biol 22:
927–934.
47. Grossmann G, Opekarova ´ M, Malinsky J, Weig-Meckl I, Tanner W (2006)
Membrane potential governs lateral segregation of plasma membrane proteins
and lipids in yeast. EMBO J 26: 1–8.
48. Walther TC, Brickner JH, Aguilar PS, Bernales S, Pantoja C, et al. (2006)
Eisosomes mark static sites of endocytosis. Nature 439: 998–1003.
49. Horvath A, Su ¨tterlin C, Manning-Krieg U, Movva NR, Riezman H (1994)
Ceramide synthesis enhances transport of GPI-anchored proteins to the Golgi
apparatus in yeast. EMBO J 13: 3687–3695.
50. Sutterlin C, Doering TL, Schimmoller F, Schroder S, Riezman H (1997)
Specific requirements for the ER to Golgi transport of GPI-anchored proteins in
yeast. J Cell Sci 110: 2703–2714.
51. Klumperman J (2000) Transport between ER and Golgi. Curr Opin Cell Biol
12: 445–449.
52. Lee MCS, Hamamoto S, Schekman R (2002) Ceramide biosynthesis is required
for the formation of the oligomeric H+-ATPase Pma1p in the yeast endoplasmic
reticulum. J Biol Chem 277: 22395–22401.
53. Spiegel S, Merrill Jr. AH (1996) Sphingolipid metabolism and cell growth
regulation. FASEB J 10: 1388–1397.
54. Gerami-Nejad M, Berman J, Gale CA (2001) Cassettes for PCR-mediated
construction of green, yellow, and cyan fluorescent protein fusions in Candida
albicans. Yeast 18: 859–864.
55. Feng Q, Summers E, Guo B, Fink G (1999) Ras signaling is required for serum-
induced hyphal differentiation in Candida albicans. J Bacteriol 181: 6339–6346.
56. Ferreira C, Lucas C (2008) The yeast O-acyltransferase Gup1p interferes in lipid
metabolism with direct consequences on the sphingolipid-sterol-ordered
domains integrity/assembly. Biochim Biophys Acta 1778: 2648–2653.
57. Zheng X, Hong L, Shi L, Guo J, Sun Z, et al. (2008) Proteomics analysis of host
cells infected with infectious bursal disease virus. Mol Cell Proteomics 7:
612–625.
58. Negredo A, Monteoliva L, Gil C, Pla J, Nombela C (1997) Cloning, analysis and
one-step disruption of the ARG5,6 gene of Candida albicans. Microbiology 143:
297–302.
Rta2p-Dependent DRMs in Candida albicans
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37768